moxisylyte has been researched along with Injuries, Spinal Cord in 5 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Excerpt | Relevance | Reference |
---|---|---|
"75 mg/kg moxisylyte on maximum urethral closure pressure were evaluated in a placebo-controlled double-blind experiment in 20 patients with spinal cord injuries." | 9.07 | Dose-related effect of moxisylyte on maximal urethral closing pressure in patients with spinal cord injuries. ( Bressolle, F; Costa, P; Mosser, J; Sabatier, R; Sarrazin, B, 1993) |
"75 mg/kg moxisylyte on maximum urethral closure pressure were evaluated in a placebo-controlled double-blind experiment in 20 patients with spinal cord injuries." | 5.07 | Dose-related effect of moxisylyte on maximal urethral closing pressure in patients with spinal cord injuries. ( Bressolle, F; Costa, P; Mosser, J; Sabatier, R; Sarrazin, B, 1993) |
" The literature search was restricted to articles published in English, French, and Spanish up to November 2014 using the key words alprostadil, papaverine, moxisylite, alpha-blocking agent, phentolamine, intracavernous injection, spinal cord injuries, paraplegia, quadriplegia, and erectile dysfunction." | 4.93 | Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis. ( Bonan, I; Chéhensse, C; Chochina, L; Damphousse, M; Giuliano, F; Manunta, A; Naudet, F, 2016) |
"Alprostadil was used 51 times, moxisylite nine times and papaverine four times." | 2.70 | [Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients]. ( Boiteau, F; Boyer, F; Dizien, O; Laffont, I; Lebib Ben Achour, S, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chochina, L | 1 |
Naudet, F | 1 |
Chéhensse, C | 1 |
Manunta, A | 1 |
Damphousse, M | 1 |
Bonan, I | 1 |
Giuliano, F | 1 |
Isambert, JL | 1 |
Egon, G | 1 |
Colombel, P | 1 |
Costa, P | 2 |
Sarrazin, B | 2 |
Bressolle, F | 2 |
Mottet, N | 1 |
Louis, JF | 1 |
Saudubray, F | 1 |
Navratil, H | 1 |
Mosser, J | 1 |
Sabatier, R | 1 |
Lebib Ben Achour, S | 1 |
Laffont, I | 1 |
Boyer, F | 1 |
Boiteau, F | 1 |
Dizien, O | 1 |
1 review available for moxisylyte and Injuries, Spinal Cord
Article | Year |
---|---|
Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Penile Erection; Prospectiv | 2016 |
2 trials available for moxisylyte and Injuries, Spinal Cord
Article | Year |
---|---|
Dose-related effect of moxisylyte on maximal urethral closing pressure in patients with spinal cord injuries.
Topics: Adolescent; Adult; Analysis of Variance; Blood Pressure; Dose-Response Relationship, Drug; Double-Bl | 1993 |
[Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Patient Satisfaction | 2001 |
2 other studies available for moxisylyte and Injuries, Spinal Cord
Article | Year |
---|---|
Adjuvant drug therapy: a review of 30 cases of sacral anterior root stimulator.
Topics: Chemotherapy, Adjuvant; Electric Stimulation Therapy; Female; Humans; Male; Moxisylyte; Muscle Contr | 1993 |
Is the volume injected a parameter likely to influence the erectile response observed after intracavernous administration of an alpha-blocking agent?
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Moxisylyte; Penile Erection; Solutions; Solve | 1993 |